AG003EYB

3228-71-5 | 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

Chemical structure of 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol, CAS 3228-71-5
AG003EYB
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 3228-71-5
Catalog Number AG003EYB(AGN-PC-0R7M86)
Chemical Name 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
EC Number 226-893-9
IUPAC Name 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChI InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)
InChI Key OIRDTQYFTABQOQ-UHFFFAOYSA-N
MDL Number MFCD00475667
Molecular Formula C10H13N5O4
Molecular Weight 267.2413
SMILES O[C@@H]1[C@@](N2C=3C(N=C2)=C(N)N=CN3)(O[C@H](CO)[C@H]1O)[H]
Synonyms
3228-71-5, 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol, .beta.-Adenosine, 5536-17-4, 9-pentofuranosyl-9H-purin-6-amine, Xylosyladenine, MLS000699527, Xylosyl A, 9-Arabinosyladenine, NSC70422, NSC247519, NSC404241, SMR000225041, 2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol, .beta.-D-Arabinosyladenine, 9- beta-D -Ribofuranosyladenine, Arabinosyl-adenine, 9.beta.-D-Arabinofuranosyladenine, Adenine .beta.-d-arabinofuranoside, NSC 7359, .beta.-D-Adenosine, Adenine, 9-.alpha.-D-xylofuranosyl-, Adenine, 9.beta.-D-arabinofuranosyl-, NSC 404241, 123179-97-5, 9H-Purin-6-amine, 9-.alpha.-D-xylofuranosyl-, 9H-Purin-6-amine, 9.beta.-D-arabinofuranosyl-, 9-.beta.-d-Ribofuranosyladenine, NSC7359, NSC7652, 9-.alpha.-D-Xylofuranosyladenine, .beta.-D-Ribofuranoside, adenine-9, 2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 9-.alpha.-D-Arabinofuranosyladenine, NSC627048, (2S,3S,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 4005-33-8, AK-54743, XA, Adenosine-8-14C, VIRDARABINE, 6-Amino-9.beta.-D-ribofuranosyl-9H-purine, Adenine, 9-.alpha.-D-arabinofuranosyl-, Opera_ID_164, 9-.beta.-Arabinoadenosine, ACMC-209m5w, REGID_for_CID_191, 9-.beta.-Arabinosyladenine, AC1L18OL, ADENOSINE, U.S.P., ACMC-1B5Q4, NCIOpen2_003303, NCIOpen2_005376, SCHEMBL63363, .beta.-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-, 9H-Purin-6-amine, 9-.alpha.-D-arabinofuranosyl-, MLS006011831, CHEMBL11909, 9.beta.-D-Ribofuranosyladenine, (2S,3S,4R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol, SCHEMBL20419324, 9-.beta.-D-Xylofuranosyladenine, CHEBI:93913, CTK4G8460, .alpha.-D-Arabinofuranosyladenine, ARA-A NSC 247519, OIRDTQYFTABQOQ-UHFFFAOYSA-N, BDBM199118, HMS2688C17, HMS3369A21, HMS3372M16, HMS3374D06, HMS3655A12, HMS3655G15, Adenine-.beta.-D-arabinofuranoside, 2946-52-3, 9-.beta.-D-Arabinofuranosyladenine, NSC-7359, NSC-7652, NSC80832, NSC87676, NSC91041, Adenine, 9-.beta.-D-xylofuranosyl-, BBL007185, MFCD00475667, NSC-70422, NSC-80832, NSC-87676, NSC-91041, STK361815, Adenine-9-.beta.-D-arabinofuranoside, AKOS005429469, AN-8229, MCULE-7671875172, NSC-247519, NSC-627048, TRA0049543, Adenine, 9-.beta.-D-arabinofuranosyl-, KS-000000A1, NCGC00015103-03, NCGC00015103-04, NCGC00015103-05, NCGC00015103-06, NCGC00094579-01, NCGC00094579-02, NCGC00094579-03, NCGC00094579-04, 4CN-0946, AK-77288, AN-10923, NCI60_003823, NCI60_037192, SC-05540, SY001357, 6-Amino-9-.beta.-D-arabinofuranosylpurine, TX-016060, 9H-Purin-6-amine, 9-a-D-arabinofuranosyl-, T8699, 9H-Purin-6-amine, 9.beta.-D-ribofuranosyl-, MFCD00005752 (98%), 9-.beta.-D-Arabinofuranosyl-9H-purin-6-amine, 9H-Purin-6-amine, 9-.beta.-D-xylofuranosyl-, L000094, I01-1121, F2ECA788-2ABC-49AB-AD84-0A0759DD3A91, WLN: T56 BN DN FN HNJ IZ D- BT5OTJ CQ DQ E1Q, 2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, adenosine, Vidarabine, Adenine xyloside, Spongoadenosine, Araadenosine, Nucleocardyl, Adenosin, Sandesin, Vidarabin, Boniton, Myocol, Adenine riboside, Arabinosyladenine, Ara-A, Adenine nucleoside, Arabinosyl adenine, Adenine arabinoside, Arabinoside adenine, Vira-A, Vira ATM, USAF CB-10, 9-beta-D-Xylofuranosyladenine, alpha-D-Arabinofuranosyladenine, CID191, 2- -5- oxolane-3,4-diol, 58-61-7, 9-alpha-D-Arabinofuranosyladenine, Adenine 9-beta-D-arabinofuranoside, Adenine-9-beta-D-arabinofuranoside, CI 673, CI-673, NSC 70422, 6-Amino-9-b-D-arabinofuranosylpurine, C10-H13-N5-O4, NSC-404241, Adenine, 9-beta-D-xylofuranosyl- (8CI), Adenine, 9-alpha-D-arabinofuranosyl- (8CI), 9H-Purin-6-amine, 9-.beta.-D-arabinofuranosyl-, 3080-29-3, (2S,3S,4R,5S)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, (2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol, 524-69-6, (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, (2R,3S,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 1070-34-4,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited